Literature DB >> 22236073

Cytokeratin 10-negative nested pattern enables sure distinction of clonal seborrheic keratosis from pagetoid Bowen's disease.

Almut Böer-Auer1, Meriem Jones, Olesya V Lyasnichaya.   

Abstract

BACKGROUND: The histopathologic pattern of clonal seborrheic keratosis (SK) is quite similar to the nested pattern of pagetoid Bowen's disease [squamous cell carcinoma in situ (SCCIS)], and differentiation between the two can be challenging, especially when only small pieces are available for interpretation.
METHODS: Eleven examples of clonal SK and 13 examples of pagetoid SCCIS were examined histopathologically (tabulating necrotic keratinocytes, suprabasal mitoses, infiltrate, parakeratosis housing plump nuclei, crowding of nuclei) and immunohistochemically (using Ki-67, bcl-2, cytokeratin 7 and cytokeratin 10). Sensitivity, specificity, p-values (Fisher's exact test, two-tailed) and positive/negative likelihood ratios (+LR/-LR) were calculated.
RESULTS: Significant differences were seen with regard to crowding (p = 0.0009) and mitoses (p = 0.0006); however, only complete absence of necrotic keratinocytes or of crowding appeared to be diagnostically convincing for a diagnosis of clonal SK (-LR < 0.01). Significant differences were also seen with bcl-2 (p = 0.0005) and cytokeratin 10 antibodies (p < 0.00001). Both markers displayed a typical nested pattern in clonal SK, nests being bcl-2-positive and cytokeratin 10-negative. Cytokeratin 10-negative nests were the most convincing criterion for differentiation between clonal SK and pagetoid SCCIS (+LR > 10, -LR < 0.01).
CONCLUSIONS: The most reliable marker to distinguish clonal SK from pagetoid SCCIS is cytokeratin 10 when it spares nests. Other criteria that assist in the differential diagnosis are bcl-2 expression, absence of crowding and of mitoses.
Copyright © 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22236073     DOI: 10.1111/j.1600-0560.2011.01825.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  7 in total

Review 1.  [Actinic keratosis, Bowen's disease, keratoacanthoma and squamous cell carcinoma of the skin].

Authors:  M Majores; E Bierhoff
Journal:  Pathologe       Date:  2015-02       Impact factor: 1.011

2.  An exophytic and symptomatic lesion of the labial mucosa diagnosed as labial seborrheic keratosis.

Authors:  Hui Feng; Binjie Liu; Zhigang Yao; Xin Zeng; Qianming Chen
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

3.  Immunohistochemical findings and differential diagnosis of papillary-type cutaneous verrucous carcinoma of the neck: A case report.

Authors:  Yoshitaka Kurisu; Motomu Tsuji; Emi Yasuda; Michiko Fujiwara; Shinichi Moriwaki
Journal:  Oncol Lett       Date:  2015-10-22       Impact factor: 2.967

4.  Diagnostic cellular abnormalities in neoplastic and non-neoplastic lesions of the epidermis: a morphological and statistical study.

Authors:  Saurabh Malhotra; Viktoryia Kazlouskaya; Christian Andres; Jiang Gui; Dirk Elston
Journal:  J Cutan Pathol       Date:  2013-02-11       Impact factor: 1.587

5.  Hypothesis: is yeast a clock model to study the onset of humans aging phenotypes?

Authors:  Cristina Mazzoni; Eleonora Mangiapelo; Vanessa Palermo; Claudio Falcone
Journal:  Front Oncol       Date:  2012-12-31       Impact factor: 6.244

6.  Evaluation of a Deep Learning Approach to Differentiate Bowen's Disease and Seborrheic Keratosis.

Authors:  Philipp Jansen; Daniel Otero Baguer; Nicole Duschner; Jean Le'Clerc Arrastia; Maximilian Schmidt; Bettina Wiepjes; Dirk Schadendorf; Eva Hadaschik; Peter Maass; Jörg Schaller; Klaus Georg Griewank
Journal:  Cancers (Basel)       Date:  2022-07-20       Impact factor: 6.575

7.  Identification and In Vitro Expansion of Buccal Epithelial Cells.

Authors:  Soraya Rasi Ghaemi; Bahman Delalat; Frances J Harding; Yazad D Irani; Keryn A Williams; Nicolas H Voelcker
Journal:  Cell Transplant       Date:  2018-06-04       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.